JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'research area tgf smad'

Search results for: 'research area tgf smad'

A8249 SB 431542
2 Citation

Summary: ALK inhibitor
A1670 Enzastaurin (LY317615)
2 Citation

Target: PKC

Summary: PKC beta inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL
A8301 GW788388

Summary: ALK5 inhibitor,potent and selective

≥21.25 mg/mL
A8348 LY2157299
2 Citation

Summary: TGF-βR1 inhibitor,potent and selective

insoluble in H2O; ≥18.45 mg/mL
A8341 Go 6976

Target: PKC

Summary: PKCα/PKCβ1 inhibitor

≥15.77 mg/mL
A8342 GF 109203X
1 Citation

Target: PKC

Summary: Protein kinase C,MLCK,PKG and PKA inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL
A8343 Go 6983
1 Citation

Summary: pan-PKC inhibitor

≥22.15 mg/mL
A8344 K-252c

Target: PKC|PKA

Summary: Protein kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥15.55 mg/mL
A8464 LY2109761
4 Citation

Summary: TβRI/II kinase inhibitor

≥22.1 mg/mL
A3132 A 77-01

Summary: Potent ALK5 inhibitor

insoluble in H2O; ≥14.3 mg/mL